Roche Diagnostics

The Roche Diagnostics International AG is the world leader in in- vitro diagnostics. Its main sites of the global Diagnostics Division is located in Rotkreuz ( municipality of Risch ) in Switzerland.

The Diagnostics Division is divided into four divisions, Roche Professional Diagnostics, Roche Molecular Diagnostics, Roche Diabetes Care and Roche Tissue Diagnostics. She knows two global functions - Global Platforms & Support and Global Operations and has since 2013 a unit " Sequencing ".

In addition to its main location in the Red Cross offices in Mannheim and Penzberg (both Germany ). Other branches with R & D activities are in the USA ( Indianapolis and Pleasanton ). Roche's Diagnostics Division employs around 23,000 people and generated 2007 sales of 9.35 billion Swiss francs.

The Divisions of Roche Diagnostics include in detail:

  • Diabetes Care - Blood glucose meters, insulin pumps, lancing devices and accessories as well as service and services for diabetics among the world's most established brand Accu- Chek ( headquartered in Basel).
  • Professional Diagnostics - integrated and decentralized system solutions for clinical and office-based laboratories, emergency medicine, clinics and private practices, IT services; Products and brand names are the Cobas Elecsys, Modular, Reflotron, Urisys etc. ( headquartered in Rotkreuz).
  • Molecular Diagnostics - based on the PCR technology diagnostic systems; Products and brand names are Cobas, etc. LightCycler ( headquartered in Pleasanton ).
  • Roche Tissue Diagnostics - Ventana, a member of the Roche Group, developed fully automated equipment, workflow solutions and reagents for tissue-based cancer diagnostics. The device systems and tumor biomarkers example, to help the pathologist in the hospital for suspected cancer tissue samples and to analyze infectious diseases quickly and to make a diagnosis. The results of the study represent an essential building block for a differentiated treatment decision and are therefore available to the physician of great importance. ( Headquartered in Tucson, Arizona, United States)

The former division "Applied Science" is resolved by the end of 2013. The PCR technology is transferred to the " Molecular Diagnostics ", other products from the clinical-chemical portfolio of " Applied Science " returns in the future of the business " Professional Diagnostics ".

COO of the diagnostic business is since 2012 Roland Diggelmann. He has assumed the role of Daniel O'Day, who moved back to Pharma.

At the Mannheim location a part of the research and development and production of diabetes and point- of-care equipment is located. In Mannheim is also the central warehouse will be supplied, from which other national companies. Furthermore done from there direct delivery to many European countries. Under construction are more office and research building, a new reception building and an additional high-bay warehouse.

Types of business entity In vitro diagnostics Pleasanton, California Polymerase chain reaction Chief Operating Officer
689107
de